Appointments and Second Opinions

Speak with one of our New Patient Coordinators to schedule an appointment, refer a patient or request a second opinion. In urgent cases, we can typically see new patients within 24 hours.

Contact us
Find Clinical Trials

We sponsor and collaborate on clinical trials that break new ground in pediatric cancer and blood disorder treatment. 

Search Pediatric Cancer and Blood Disorder Clinical Trials
Our Affiliations
HMS Affiliate

Dana-Farber/Boston Children's is a teaching affiliate of Harvard Medical School.

Our Affiliations

Jennifer M. Snaman, MD

  • Physician
  • Assistant Professor of Pediatrics, Harvard Medical School

Appointment Phone

  • 617-632-3270
  • 888-733-4662

Fax

  • 617-582-7271

General

Treatment Centers

Discipline

Clinical Interests

Parental grief and bereavement, Pediatric neuro-oncology, Pediatric palliative care, Serious illness communication

Location

Background

Board Certifications

  • Hospice and Palliative Medicine
  • Pediatric Hematology/Oncology
  • Pediatrics

Fellowship

  • St. Jude Children’s Research Hospital, Pediatric Hematology/Oncology
  • University of Tennessee Health Science Center/St. Jude Children’s Research Hospital, Hospice and Palliative Care

Residency

  • Boston Combined Residency Program, Boston Children's Hospital/Boston Medical Center, Pediatrics

Medical School

  • Eastern Virginia Medical School

Biography

 

Jennifer Snaman, MD, MS, is an Assistant Professor at Harvard Medical School and an Attending Physician in pediatric oncology and pediatric palliative care at Dana-Farber Cancer Institute and Boston Children’s Hospital. She developed a four-year combined Pediatric Hematology/Oncology (PHO) and Pediatric Hospice and Palliative Medicine (HPM) Fellowship training at St. Jude. She served as Chief Fellow for the PHO fellowship before coming to Dana-Farber in 2017. 

Her research interests include communication and decision making in adolescent and young adult (AYA) patients with advanced cancer and early parental grief following the death of a child from cancer. She developed MyPref, an adaptive conjoint analysis-based decision and communication tool used to quantify and communicate medical treatment preferences in AYA patients with high-risk cancer. Through her partnership with bereaved parents, she has worked to illuminate the early bereavement experience following the death of a child from cancer with the goal of developing and testing additional supportive interventions. She became the Director of Pediatric Palliative Care Research at Dana-Farber and Boston Children’s Hospital in 2023 and co-leads the Palliative Care and Resilience (PCAR) Lab together with Drs. Abby Rosenberg and Joyce Yi-Frazier. Her research is currently supported by grants from the American Cancer Society and National Cancer Institute.